KFSHRC and CellCo Sign MoU to Advance Biosynthetic Heparin (Bioxaparin™) & Next-Generation Therapeutics in Saudi Arabia
RIYADH, SAUDI ARABIA, October 29, 2025 /EINPresswire.com/ -- King Faisal Specialist Hospital and Research Centre (KFSHRC) and The Cell Company (CellCo) signed a memorandum of understanding to establish a strategic collaboration that advances the …